M Furutani
- Hepatology top 5%
- Liver physiology and pathology 3
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 3
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
-
- Angiogenesis and VEGF in Cancer 4
-
- Liver Disease Diagnosis and Treatment 3
-
- Drug-Induced Hepatotoxicity and Protection 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Shigeki AriiM ImamuraT. HARADAMasanori NiwanoS IshigamiMasaki MizumotoM MiseHisashi Onodera
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- JapanUnited States
In The Last Decade
M Furutani
16 papers receiving 961 citations
Peers
Comparison fields: 5 of 74
- Hepatology 236
- Cancer Research 378
- Oncology 354
- Molecular Biology 593
- Pathology and Forensic Medicine 106
Countries citing papers authored by M Furutani
This map shows the geographic impact of M Furutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Furutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Furutani more than expected).
Fields of papers citing papers by M Furutani
This network shows the impact of papers produced by M Furutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Furutani. The network helps show where M Furutani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Furutani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 24 | |
| 2 | 2000 | 53 | |
| 3 | 2000 | 10 | |
| 4 | Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. | 2000 | 69 |
| 5 | Identification of Macrophage Metalloelastase in Hepatocellular Carcinoma:Correlation With Angiostatin Generation and its Clinical Significance | 1998 | 5 |
| 6 | 1998 | 5 | |
| 7 | 1998 | 294 | |
| 8 | 1996 | 10 | |
| 9 | 1996 | 270 | |
| 10 | 1996 | 2 | |
| 11 | 1996 | 165 | |
| 12 | 1996 | 2 | |
| 13 | Suppression of the reperfusion injury of cold-preserved livers by Kupffer cell blockade. | 1995 | 2 |
| 14 | Enhanced expression of multiple protein tyrosine phosphatases in the regenerating mouse liver: isolation of PTP-RL10, a novel cytoplasmic-type phosphatase with sequence homology to cytoskeletal protein 4.1. | 1995 | 26 |
| 15 | 1995 | 23 | |
| 16 | Immunologic activation of hepatic macrophages in septic rats: a possible mechanism of sepsis-associated liver injury. | 1994 | 19 |
About M Furutani
M Furutani is a scholar working on Hepatology, Cancer Research and Pharmacology, having authored 16 papers that have together received 979 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Liver physiology and pathology (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Protease and Inhibitor Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Hepatology (236 citations), Cancer Research (378 citations) and Oncology (354 citations). M Furutani has collaborated with scholars based in Japan and United States. Frequent co-authors include Shigeki Arii, M Imamura, T. HARADA, Masanori Niwano, S Ishigami, Masaki Mizumoto, M Mise, Hisashi Onodera, Akihiro Mori and Hidenori Nakayama. Their work appears in journals such as Hepatology, British Journal of Cancer, Oncology Reports, Biochemical Journal and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.